The use of SGLT-2 inhibitors produces cardiovascular benefits and reduces the risk of progression of renal impairment in patients with T2DM.
Read More »Lower Treatment Rates of Depression For Some Type 2 Patients
Does being a member of a minority ethnicity put you at risk of being overlooked for depression?
Read More »What does Resistant Hypertension Mean for Diabetes Patients?
Can a diagnosis of resistant hypertension give clinicians a clue on what patients can expect for their future?
Read More »Canagliflozin’s Efficacy and Safety For Delaying and Possibly Preventing ESKD
Kidney failure is an enormous concern for people with T2D and DKD. This analysis confirms canagliflozin can slow its progression and have an impact on patients regardless of their level of kidney function.
Read More »Sleep: Why it’s Crucial for Teens with Diabetes
This study covers the implications of sleep and its effect on behavioral and physiological implications in teens with type 1 diabetes.
Read More »A New Medication Class for Children with Diabetes
The results of a recent phase III study may offer children with diabetes a new route for better glycemic control.
Read More »Comparison of Gastric Bypass Outcomes in Adolescents and Adults Five Years Post Op
The study findings explore the gastric bypass results of different age groups in hopes of learning more about the procedure and the potential risks and benefits that come with it.
Read More »Metformin vs. Sulfonylurea To Lower Dementia Risk In T2D
A recent study found important effects on dementia in African American patients with type 2 diabetes
Read More »Prevalence of Unrecognized Myocardial Infarction in Asymptomatic Patients With Diabetes
Can using DE-MRI image scans determine the prevalence of unrecognized MIs in asymptomatic patients with diabetes?
Read More »Benefits of Pioglitazone Plus Insulin For Type 2
Combination dual therapy reduces mortality by 50%.
Read More »